|
|
BioSerenTach is aggressively and globally looking for partners.
We actively look for partners which suffer from bioavailability problem
of API.
BioSerenTach codevelops suitable formulations for API with our DDS technologies. |
| BioSerenTach Inc. |
| Head office |
Shimizu-cho 389, Nakagyo-ku, Kyoto 604-0874, Japan |
| Tel |
075-746-2160 (from abroad 81-75-746-2160)
|
| Fax |
075-746-2160 (from abroad 81-75-746-2160) |
| Established |
August 1, 2001 |
| E-mail |
info@bioserentach.co.jp |
| Chairman |
Prof. Kanji Takada, Ph. D. |
| President |
Yasuyo Takada |
| Capitalization |
￥10,000,000 |
| Main Bank |
Kyoto Bank |
|
Copyright BioSerenTach Inc, 2021
|
|
